Search company, investor...



Other Investors | Alive

About Automedx

AutoMedx Inc. was founded to improve the survival rate of individuals suffering acute respiratory failure by providing unparalleled access to mechanical ventilation during a critical minutes of respiratory distress. One of the top ten causes of death in the United States, acute respiratory failure remains a major cause of mortality in pediatric and adult populations. The SAVe's ease of use aims to enable any non-medical first responder the ability to provide life saving mechanical ventilation until an EMS team arrives on scene or until the patient is transported to a medical facility.

Headquarters Location

12321 Middlebrook Rd Ste 150

Germantown, Maryland, 20874,

United States


Missing: Automedx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Automedx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Automedx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Automedx is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Automedx Patents

Automedx has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Respiratory therapy, Mechanical ventilation, Intensive care medicine, Medical equipment, Pulmonology


Application Date


Grant Date



Related Topics

Respiratory therapy, Mechanical ventilation, Intensive care medicine, Medical equipment, Pulmonology



Latest Automedx News

White House ventilator deal under investigation

Jan 28, 2021

byREED ALBERGOTTI AND AARON GREGG THE WASHINGTON POST|Today at 4:11 a.m. WASHINGTON -- A House subcommittee is investigating a government deal to buy $70 million worth of ventilators for the pandemic response after reports that they were inadequate for treating most covid-19 patients. Last spring, as part of its effort to increase the number of ventilators for treating the coronavirus, the Department of Health and Human Services and the Defense Logistics Agency purchased 11,200 AutoMedx SAVe II+ ventilators from Combat Medical Systems, which distributes the devices. But the ventilators were inadequate for treating covid-19 patients and remain in warehouses, according to Stephanie Bialek, a spokeswoman for the Strategic National Stockpile. "AutoMedx appears to be the beneficiary of a potentially tainted procurement process," said Rep. Raja Krishnamoorthi, D-Ill., the leader of the House Subcommittee on Economic and Consumer Policy, which is in charge of the investigation, wrote in letters sent to the companies on Wednesday. The Washington Post previously reported that AutoMedx's co-founder and current shareholder, Adrian Urias, advised the Trump administration's covid-19 task force on ventilator purchases. In March, when the U.S. government posted the minimum specifications ventilator manufacturers must meet to sell devices for the pandemic response, those specifications were nearly identical to a specifications sheet listed on AutoMedx's website at the time. Krishnamoorthi, who is likely to continue on as chairman, cited Urias' role on the task force and the similarity of the specifications in his letters. The fact that the AutoMedx ventilators are ill-suited for covid-19 patients "raises serious questions about whether their purchase for nearly $70 million constitutes waste, fraud, or abuse," he wrote. In letters to Combat Medical and AutoMedx, the committee requested documents and communications related to the contract and a description of negotiations with the federal government. The committee also requested any communications related to the principals at the company, as well as prominent officials in President Donald Trump's administration, such as the former president's son-in-law, Jared Kushner, former Health and Human Services secretary Alex Azar and adviser Peter Navarro, the director of trade and manufacturing policy who helped coordinate efforts to produce medical supplies for the pandemic response. The Democrat-controlled House Subcommittee on Economic and Consumer Policy, part of the House Committee on Oversight and Reform, has been investigating the federal approach to ventilator procurement since mid-April, when a White House-led task force sought to quickly procure medical supplies as the virus spread. Widespread ventilator shortages never materialized. But the U.S. government was left with a trove of ventilators acquired through hastily arranged agreements with manufacturers. One contract with the medical device manufacturer Phillips was subject to a fivefold price increase after it was renegotiated by Trump administration officials. The committee concluded that the waste of taxpayer funds caused by the Trump administration's ventilator procurement could be as high as $500 million. A report in Pro Publica spurred the Phillips investigation. The contract for AutoMedx ventilators, at about $70 million, is relatively small in the broader context of the hundreds of billions of dollars spent on covid-19 relief. But the company's apparent connections to the White House team that coordinated ventilator response raised questions about the fairness of the selection process. After the initial contract to purchase the AutoMedx SAVe II ventilator in March, several military doctors and medical personnel expressed misgivings about the appropriateness of the SAVe II ventilator for covid treatment in an email chain reviewed by the Post, raising broader concerns about whether the national stockpile received the right products. Doctors familiar with the SAVe II called it "awful and underpowered," according to the emails. One military doctor said an underpowered ventilator could "kill [covid patients] just as fast as no ventilator at all." Rather than back out of the contract, the Department of Health and Human Services requested that Combat Medical Systems make a new ventilator with improved features, according to Katie McKeogh, a spokeswoman for the department. That ventilator became the SAVe II+, a device with improved capabilities but one emergency room doctors say is still inadequate for the pandemic response. ADVERTISEMENT Sponsor Content COMMENTS - It looks like you're using Internet Explorer, which isn't compatible with the Democrat-Gazette commenting system. You can join the discussion by using another browser, like Firefox or Google Chrome . It looks like you're using Microsoft Edge. The Democrat-Gazette commenting system is more compatible with Firefox and Google Chrome . ADVERTISEMENT

Automedx Frequently Asked Questions (FAQ)

  • Where is Automedx's headquarters?

    Automedx's headquarters is located at 12321 Middlebrook Rd Ste 150, Germantown.

  • What is Automedx's latest funding round?

    Automedx's latest funding round is Other Investors.

  • Who are the investors of Automedx?

    Investors of Automedx include Jefferson Corner Group.

  • Who are Automedx's competitors?

    Competitors of Automedx include Breathe Technologies, Heartsine, Zonare Medical Systems, Triangle Biomedical Sciences, Dormir and 11 more.

Compare Automedx to Competitors

Paradigm Systems

Paradigm Systems remanufactures, services and sells homecare medical equipment.

Skytron Logo

Skytron aims to provide clinical equipment for the company's healthcare customers.

Calumet Coach

Calumet Coach is a manufacturer of mobile coaches and trailer for CAT, MRI equipment

Kalypto Medical

Kalypto Medical, Inc. sells wound-care products.


Manufactures and sells a system which will automatically clean and disinfect all types of contact lenses, without chemicals, surfactants, or enzymes.

Magic Wheels Logo
Magic Wheels

Magic Wheels aims to turn wheelchairs into two-gear wheelchairs to make it easier for wheelchair users to get around.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.